Home » Topics » Briefs » Other news to note

Other news to note
RSS

New companies created: Evelo Therapeutics, Aziyo Biologics and Iron Horse Therapeutics

Nov. 9, 2015

Takeda reflects on accomplishments of second quarter of fiscal 2015

Nov. 9, 2015

Axovant acquires nelotanserin, expands development of RVT-101

Nov. 6, 2015

AstraZeneca to acquire ZS Pharma

Nov. 6, 2015

AbbVie reports highlights of third quarter 2015

Nov. 6, 2015

Daiichi Sankyo offers overview of second quarter of fiscal 2015

Nov. 6, 2015

Astellas Pharma presents milestones of second quarter of fiscal 2015

Nov. 6, 2015

Johnson & Johnson to acquire Novira Therapeutics

Nov. 5, 2015

Eisai reviews achievements of second quarter of fiscal 2015

Nov. 5, 2015

Sanofi profiles regulatory and development activities of third quarter 2015

Nov. 5, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...